402 related articles for article (PubMed ID: 16477234)
1. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
[TBL] [Abstract][Full Text] [Related]
2. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
5. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice.
Dai H; Zhu H; Lei P; Yagita H; Liu J; Wen X; Zhou W; Gong F; Shen G; Fang M
Transplantation; 2009 Oct; 88(7):864-73. PubMed ID: 19935456
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
9. [Rapamycin combined with donor bone marrow-derived immature dendritic cells induces mouse skin allograft tolerance].
Yu S; He X; Hu A; Fu BM; Ma Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):399-402. PubMed ID: 18359700
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.
Emmer PM; van der Vlag J; Adema GJ; Hilbrands LB
Transplantation; 2006 May; 81(10):1451-9. PubMed ID: 16732184
[TBL] [Abstract][Full Text] [Related]
12. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
13. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
[TBL] [Abstract][Full Text] [Related]
14. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
15. [Pretreatment of donor dendritic cells with NBD-peptide prolongs mouse cardiac allograft survival].
Su G; Zhao WZ; Chen JJ; Xu J; Qiao CH; Liu C; Sun ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1562-7. PubMed ID: 18819868
[TBL] [Abstract][Full Text] [Related]
16. [Impact of novel negative immunoregulatory dendritic cells on regulatory T cells in cardiac allograft recipient rats].
Zheng DH; Shi BY; Zou YP; Cai M; Qian YY; Hong BF; Dou LP; Li L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jan; 26(1):13-7. PubMed ID: 20056079
[TBL] [Abstract][Full Text] [Related]
17. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
Roelen DL; Schuurhuis DH; van den Boogaardt DE; Koekkoek K; van Miert PP; van Schip JJ; Laban S; Rea D; Melief CJ; Offringa R; Ossendorp F; Claas FH
Transplantation; 2003 Dec; 76(11):1608-15. PubMed ID: 14702533
[TBL] [Abstract][Full Text] [Related]
18. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
19. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
20. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
Zhu XH; Chen S; Chen ZK
Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
